Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting
August 6, 2025
In this podcast, Dr. Zoe Ngo and Dr. Austin Wang discuss the AJHP Case Study "Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting” with host and AJHP Editor in Chief Dr. Daniel Cobaugh.
SPEAKERS
Zoe Ngo, Pharm.D. is a quality compliance coordinator at Stanford Health Care Investigational Drug Service. Her career in investigational drugs led to a strong interest in the safe handling of novel therapeutics. She participates in the risk assessment review committee, promoting best practices for the safe handling of hazardous drugs, and has published on the risk assessment process for biologics. Additionally, she serves as a pharmacy liaison for multiple clinical trials as a member of the Alliance for Clinical Trials Pharmacy Committee, supporting pharmacies across the U.S. and Canada in conducting high-quality research.
Austin Wang, Pharm.D., BCPS is a pharmacy supervisor for pharmaceutical procurement and inventory operations at Stanford Health Care. He received his Pharm.D. from the University of Southern California and completed his PGY-1 pharmacy residency at Stanford Health Care. His prior practice settings include acute care pharmacy and investigational drug services.
Daniel J. Cobaugh, Pharm.D., FAACT, DABAT is the senior vice president of professional development and publishing at ASHP and the editor-in-chief of AJHP. He has served on the ASHP staff since 2002. He received his B.S. in Pharmacy from the University of Pittsburgh and his Doctor of Pharmacy from Duquesne University. Cobaugh completed an ASHP-accredited residency in hospital pharmacy at Mercy Hospital of Pittsburgh and a clinical toxicology fellowship at the Pittsburgh Poison Center. He practiced as pharmacist-clinical toxicologist and held faculty appointments at the University of Pittsburgh Medical Center and the University of Rochester Medical Center.
LISTEN ON
The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
ADVERTISEMENT